2022
DOI: 10.1111/odi.14411
|View full text |Cite
|
Sign up to set email alerts
|

Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance

Abstract: Head and neck squamous cell carcinoma (HNSCC) is among the most prevalent cancer worldwide, with the most severe impact on quality of life of patients. Despite the development of multimodal therapeutic approaches, the clinical outcomes of HNSCC are still unsatisfactory, mainly caused by relatively low responsiveness to treatment and severe drug resistance. Metabolic reprogramming is currently considered to play a pivotal role in anticancer therapeutic resistance. This review aimed to define the specific metabo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 203 publications
0
2
0
Order By: Relevance
“…However, if the formation of distant metastasis occurs, it is also associated with a very poor prognosis [10][11][12]. Several pathways have been suggested to be involved in acquired and intrinsic resistance development, dissemination, and recurrence of HNSCC and have been recently reviewed in [2,13,14]. Here, we highlight the current knowledge of the process of epithelial-mesenchymal transition (EMT) in HNSCC.…”
Section: Introductionmentioning
confidence: 99%
“…However, if the formation of distant metastasis occurs, it is also associated with a very poor prognosis [10][11][12]. Several pathways have been suggested to be involved in acquired and intrinsic resistance development, dissemination, and recurrence of HNSCC and have been recently reviewed in [2,13,14]. Here, we highlight the current knowledge of the process of epithelial-mesenchymal transition (EMT) in HNSCC.…”
Section: Introductionmentioning
confidence: 99%
“…Although the early stage of SCC predisposes better than the advanced stage, there is still a mortality rate of 13% to 30%. The diagnosis appears to be closely related to perineural distance from SCC ("negative perineural invasion") [11][12][13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, high glycolytic activity measured based on 18F-FDG positron-emission tomography was a negative prognostic factor for HNSCC patients [10]. Thus, metabolic pathways are now considered potential targets of HNSCC therapy [11,12].…”
Section: Introductionmentioning
confidence: 99%